ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/07/2026
Voltar para busca
Dado oficial do USPTO
NOVO NORDISK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079290058Classe
1, 5, 9, 10, 41, 42, 44
Pedido
79290058
Registro
6317854
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
02/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 41, 42, 44
Data de depósito
03/04/2020
Data de registro
13/04/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/04/2021
Última transação
02/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
DK
Examinador
EVANKO, PATRICIA MALESARDI
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "NOVO NORDISK" below a design of a bull with a circle above its head, all in the color blue.
Titulares e representantes
Titulares
Novo Nordisk A/S
Representantes
Alexander Reid White & Case LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for use in industry; chemical additives for use in the manufacture of pharmaceuticalscosmeticshair lotionsdisinfectants; chemical diagnostic reagents for industrial usefor non-medical and non-veterinary purposes; chemical preparations for use in the oil industry
Classe 5
Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing pharmaceutical preparations for haemostasis managementpharmaceutical preparations for the treatment of sickle cell diseasebrain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasepharmaceutical preparations for hormone therapy and stem cells for medical purposes; chemical preparations for use in medical devicesdrug delivery agents consisting of compounds that deliver a wide range of pharmaceuticals
Classe 9
downloadable electronic publicationsleafletsbooksbookletshandoutsmagazinesas well as medicalinstructional and teaching material in the field of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable software applications for use with mobile devices for monitoring and management of medical data related to diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; computer hardware and downloadable softwarefor use with medical injection devices for collectingtransmittingdisplaying medical data; downloadable medical software for the management of medical data related to diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; downloadable software as a medical devicesoftware used in connection with medical devices to manage treatment of haemostasis management and for the treatment of sickle cell diseasebrain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cells for medical purposes
Classe 10
Medical and surgical apparatus and instrumentshypodermic syringes and syringe pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instrumentsinjection devices for administration of pharmaceutical preparationsmedical infusion pumps for delivering measured amounts of solutions into the bloodstream over timeinfusion pump controllersadhesive infusion devices for administering drugs; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; medical and surgical apparatus and instrumentsinjection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; medical devicesautomatic needle insertion devicesprotection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration of pharmaceutical preparations
Classe 41
Educational servicesorganizing and conducting educational programmescoaching and training services for patients and healthcare professionals related to management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; arranging and conducting of educational conferencescongressesseminarssymposiums and workshops related to the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Classe 42
Providing scientific research information in the field of diabetesobesityhaemostasis managementtreatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; providing temporary use of online non-downloadable software featuring technology that enables users to recordtrackgenerate reports regarding the conditiontreatment and the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Classe 44
Providing medical services via websites and mobile apps for the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment; providing medical information and medical counselling featuring the management of diabetesobesityhaemostasis management and for the treatment of sickle cell diseasetreatment of brain disordersnon-alcoholic steatohepatitisatherosclerosiscardiovascular diseasechronic kidney diseasehormone therapy and stem cell treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/08/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/07/2021
FIMP
FINAL DISPOSITION PROCESSED
27/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
13/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
06/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/01/2021
PUBO
PUBLISHED FOR OPPOSITION
26/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/01/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
17/12/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/12/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
17/12/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/12/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
09/12/2020
CRSN
CORRECTION SENT TO IB
18/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/10/2020
RFNT
REFUSAL PROCESSED BY IB
27/09/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2020
RFRR
REFUSAL PROCESSED BY MPU
02/09/2020
CRCR
CORRECTION CREATED FOR IB
01/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/07/2020
CNRT
NON-FINAL ACTION WRITTEN
29/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/07/2020
DOCK
ASSIGNED TO EXAMINER
24/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVO NORDISK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.